Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2004

Nov 8, 2004

29777_dirs_2004-11-08_40132f3c-3fa2-4b1f-a402-557712ffabe8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2004-11-04

Reporting Person: FREYMAN THOMAS C (Executive VP, Finance & CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2004-11-04 Common shares without par value M 2875 $34.7727 Acquired 179112 Direct
2004-11-04 Common shares without par value F 2292 $43.61 Disposed 176820 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2004-11-04 Option (right to buy) $34.7727 M 2875 Disposed 2008-02-12 common shares (2875) Direct
2004-11-04 Option (right to buy) $43.61 A 2292 Acquired 2008-02-12 common shares (2292) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 16696 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of November 4, 2004.

F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.